Abstract
HER2-enriched breast cancer is a complex disease characterized by the overexpression of the ERBB2 amplicon. While the effects of this genomic aberration on the pathology have been studied, genome-wide deregulation patterns in this subtype of cancer are also observed. A novel approach to the study of this malignant neoplasy is the use of transcriptional networks. These networks generally exhibit modular structures, which in turn may be associated to biological processes. This modular regulation of biological functions may also exhibit a hierarchical structure, with deeper levels of modular organization accounting for more specific functional regulation. In this work, we identified the most probable (maximum likelihood) model of the hierarchical modular structure of the HER2-enriched transcriptional network as reconstructed from gene expression data, and analyzed the statistical associations of modules and submodules to biological functions. We found modular structures, independent from direct ERBB2 amplicon regulation, involved in different biological functions such as signaling, immunity, and cellular morphology. Higher resolution submodules were identified in more specific functions, such as micro-RNA regulation and the activation of viral-like immune response. We propose the approach presented here as one that may help to unveil mechanisms involved in the development of the pathology.
Highlights
Breast cancer is the malignant neoplasy with the highest incidence and mortality among women worldwide (Ferlay et al, 2014)
In the case of biological networks, there is a search for modular partitions that may reflect a semi-mechanistic structure in which particular modules are responsible to carry out certain biological functions
The graph partition algorithm used here (InfoMap/MapEquation) is based on the consideration of an ensemble of random walkers performing stochastic trajectories over the network, a coding procedure is performed on the trajectories generating an ensemble of travel codes that are subject to minimum description length optimization
Summary
Breast cancer is the malignant neoplasy with the highest incidence and mortality among women worldwide (Ferlay et al, 2014). HER2+ breast cancer is characterized by the overexpression of the HER2 receptor, encoded in the ERBB2 gene located on Chromosome 17: Amplification of the Chr17q12 locus leads to the overexpression of the receptor that can be identified through immunohistochemical and transcriptomic approaches (Perou et al, 2000; Burstein, 2005). This HER2 amplicon includes genes such as STARD3, GRB7, PGAP3, TOP2, MED1, THRA, RARA, IGFPB4, CCR7, KRT20, KRT19, and GAST
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.